BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26032634)

  • 1. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
    Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
    Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.
    Pan H; Chen J; Shen K; Wang X; Wang P; Fu G; Meng H; Wang Y; Jin B
    PLoS One; 2015; 10(4):e0124775. PubMed ID: 25875356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity.
    Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Toxicology; 2008 Mar; 245(1-2):18-23. PubMed ID: 18243469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis.
    Mahgoub E; Kumaraswamy SM; Kader KH; Venkataraman B; Ojha S; Adeghate E; Rajesh M
    Biomed Pharmacother; 2017 Sep; 93():1083-1097. PubMed ID: 28738532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis.
    El-Naga RN
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):87-95. PubMed ID: 24211271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprotective effects of curcumin on doxorubicin-induced nephrotoxicity in wistar rats: by modulating inflammatory cytokines, apoptosis, oxidative stress and oxidative DNA damage.
    Benzer F; Kandemir FM; Kucukler S; Comaklı S; Caglayan C
    Arch Physiol Biochem; 2018 Dec; 124(5):448-457. PubMed ID: 29302997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity.
    Gang GT; Kim YH; Noh JR; Kim KS; Jung JY; Shong M; Hwang JH; Lee CH
    Toxicol Lett; 2013 Aug; 221(3):165-75. PubMed ID: 23831944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of cisplatin-induced nephrotoxicity by extracts of Hemidesmus indicus and Acorus calamus.
    Sandeep D; Krishnan Nair CK
    Pharm Biol; 2010 Mar; 48(3):290-5. PubMed ID: 20645815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of Ribes diacanthum Pall on cisplatin-induced nephrotoxicity in mice.
    Tilyek A; Chai C; Hou X; Zhou B; Zhang C; Cao Z; Yu B
    J Ethnopharmacol; 2016 Feb; 178():297-306. PubMed ID: 26481606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress.
    Gómez-Sierra T; Molina-Jijón E; Tapia E; Hernández-Pando R; García-Niño WR; Maldonado PD; Reyes JL; Barrera-Oviedo D; Torres I; Pedraza-Chaverri J
    J Pharm Pharmacol; 2014 Sep; 66(9):1271-81. PubMed ID: 24779924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs.
    Helmy MM; Helmy MW; El-Mas MM
    PLoS One; 2015; 10(11):e0142303. PubMed ID: 26536032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.
    Nojiri T; Hosoda H; Kimura T; Miura K; Ishikane S; Tokudome T; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):123-9. PubMed ID: 25385303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of safranal to cisplatin-induced nephrotoxicity.
    Karafakıoğlu YS; Bozkurt MF; Hazman Ö; Fıdan AF
    Biochem J; 2017 Mar; 474(7):1195-1203. PubMed ID: 28188255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.
    Ferjani H; El Arem A; Bouraoui A; Achour A; Abid S; Bacha H; Boussema-Ayed I
    J Physiol Biochem; 2016 Jun; 72(2):133-44. PubMed ID: 26746208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress.
    Jing T; Liao J; Shen K; Chen X; Xu Z; Tian W; Wang Y; Jin B; Pan H
    Food Chem Toxicol; 2019 Jul; 129():108-114. PubMed ID: 31014901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
    Sahu BD; Kuncha M; Sindhura GJ; Sistla R
    Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
    Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.
    Nakashima-Kamimura N; Mori T; Ohsawa I; Asoh S; Ohta S
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):753-61. PubMed ID: 19148645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.